Clinical Peptides

Clinical Peptides| cGMP Peptide Production|IND Filed Peptides|Tshuaj Kho Mob|Kev tshawb fawb-Peptide

Xav tau Clinical Peptides rau IND filing lossis kev sim tshuaj? Science-Peptide muab Clinical Peptides cGMP manufacturing service, npog Phase I-III kuaj kuaj, ua raws li FDA/EMA cov qauv, 20 xyoo dhau los, tshaj 100 batch tau xa. Txais tos tiv tauj peb.

Vim li cas Clinical Peptides cov kev cai txawv?
Tus neeg twg uas tau ua cov tshuaj peptide txhim kho paub tias txawm tias koj ua tau zoo hauv chav kuaj, nws yog lwm qhov teeb meem thaum koj nkag mus rau hauv tsev kho mob. Cov neeg tswj xyuas tau saib xyuas txhua qhov kev nthuav dav - qhov twg cov khoom siv raw los ntawm, cov txheej txheem tswj hwm li cas, muaj pes tsawg impurities muaj, thiab cov khoom ruaj khov npaum li cas.

 

Nov yog qhov txawv ntawm Clinical Peptides thiab Kev Tshawb Fawb Qib Peptides:
Qib tshawb fawb:tsuas yog txaus, feem ntau yog nyob ntawm qhov kev ua si
Kev siv tshuaj kho mob:Txhua batch yuav tsum auditable, txhua daim ntaub ntawv yuav tsum traceable

Kev tshawb fawb-Peptide tau ua haujlwm hauv thaj chaw kho mob Peptides tau 20 xyoo, thiab tau pab cov neeg siv khoom los ntawm tag nrho cov txheej txheem los ntawm IND ua ntaub ntawv mus rau Phase III lub tsev kho mob. Tam sim no, peb tau xa ntau tshaj 100 pawg ntawm kev kho mob peptides, npog tag nrho cov theem ntawm toxicology mus rau txheej txheem validation.

1. Npog tag nrho Cov Kev Kho Mob Kev Txhim Kho

2. Hom Tshuaj Kho Mob Peptides peb tuaj yeem ua tau

• Linear peptides: 2-50 amino acids, ntau yam ntev
• Cyclic peptides: thawj zaug thiab kawg cyclization, sab saw cyclization, disulfide bond cyclization
• Hloov pauv peptides: PEGylation, fatty acid hloov kho, phosphorylation, acetylation
• Complex peptides: ntau khub ntawm disulfide bonds, stapled peptides, glycopeptides

3. CGMP Ntau Lawm Muaj Peev Xwm

Txhua qhov chaw yog FDA / EMA cGMP raws, ISO tau ntawv pov thawj thiab raug rau cov neeg siv khoom tshawb xyuas.

4. Cov kev tswj xyuas zoo
Kev tswj kom zoo ntawm tag nrho cov txheej txheem: intermediates, crude peptides, purified peptides, impurity profiles, txhua qhov ntawm no yog daig

• Kev kuaj pom muaj peev xwm: HPLC, UPLC, MS, MS / MS, amino acid tsom xam, ya raws, residual kuab tshuaj, endotoxins, kab mob, cov impurities elemental
• Kev tshawb fawb txog kev ruaj ntseg: ntev-lub sij hawm, nrawm, muaj feem cuam tshuam, kev txhawb nqa rau kev tsim kho hnub tas sij hawm

1. 20 xyoo dhau los, ntau tshaj 100 qhov chaw kho mob
Clinical peptides tsis yog rau txhua tus. Peb tau nyob hauv kev lag luam rau 20 xyoo thiab tau xa ntau tshaj 100 pawg ntawm kev kho mob peptides, npog tag nrho cov theem ntawm IND ua rau Phase III. Muaj ntau dua 10 APIs nyob rau hauv kev ua lag luam - Atosiban, Terlipressin, Octreotide, Cetrorelix, thiab lwm yam, thiab txhua tus ntawm lawv tau dhau los ua tiav cov txheej txheem validation thiab stability kev tshawb fawb.

2. txheej txheem amplification: tsis tsuas yog hloov lub raj mis nrog ib tug loj dua
Yog tias koj ua tau zoo hauv qhov kev sim me me, qhov ntsuas - nce yuav tsis du. Kev sib xyaw ua haujlwm hloov pauv, qhov kub thiab huab cua hloov pauv txawv, thiab qhov tsis zoo ntawm qhov profile kuj tseem tuaj yeem hloov pauv. Peb tau raug kev txom nyem los ntawm kev nce qib, tab sis peb kuj tau txais kev paub:

• Khoom-theem amplification: Optimize resin xaiv, dosing ratio thiab ntxuav txoj kev kom batch{1}}rau-batch reproducibility
• Kua theem amplification: ntev peptides los yog hydrophobic peptides, kua theem txoj kev yog ntau yig, peb tshwj xeeb hauv kev tsim hybridization txoj kev
• QbD lub tswv yim: Xav txog kev nthuav dav ntawm theem kev txhim kho, txheeb xyuas cov txheej txheem tseem ceeb ua ntej

3. Kev tswj hwm impurity, tshaj tawm tsis yog -treading
Dab tsi yog Clinical Peptides ntshai tshaj plaws? Ib qho impurity profile uas tsis meej, lossis ib qho impurity uas tsis muaj kev txwv. Peb tsom mus rau impurities los ntawm cov txheej txheem kev txhim kho theem:

• Kev txheeb xyuas qhov chaw rau txhua tus txheej txheem impurity
• Cov impurities tseem ceeb yog synthesized cais raws li kev tswj
• Heterogeneous huab hwm coj spectrometry thiab thawj kev tshawb fawb sib piv los xyuas kom meej controllability

4. Kev sau cov ntaub ntawv, uas pab koj txo tus lej ntawm cov kauj ruam koj yuav tsum ua
Tus neeg twg uas tau ua daim ntawv tso cai kho mob paub tias nws yuav nyuaj npaum li cas los npaj cov ntaub ntawv. Peb tuaj yeem muab:

• Cov ntaub ntawv DMF (tso cai tso cai)
• Cov txheej txheem validation report (program + results)
• Impurity Profileing (txheej txheem impurities + degradation impurities)
• Cov ntaub ntawv ruaj khov (txhawb nqa lub sijhawm rov ntsuas dua)
• Hloov tswj thiab tswj kev sib txawv (raws li ICH Q10)
• Cov ntaub ntawv no tau pab ntau ntawm peb cov neeg siv khoom kom ua tiav FDA thiab EMA tshuaj xyuas.

5. Cov saw hlau, yog li koj tsis raug txiav tawm
Dab tsi yog qhov ntshai tshaj plaws ntawm kev ua Clinical Peptides? Poob cov ntaub ntawv raw thaum ua haujlwm rau nws. Peb:

• Muab ob npaug rau: resins, amino acids, cov kuab tshuaj, yam tsawg kawg yog ob tus neeg muag khoom tsim nyog
• Strategic stockpiling: tswj kev ruaj ntseg ntawm cov khoom siv feem ntau
• Ntau-puag ntau lawm: R&D, Pilot thiab Commercialization hauv peb cov nroj tsuag kom muaj kev txaus ntshai

6. Cov ntaub ntawv yooj yim ntawm kev koom tes
Txawm hais tias koj yog lub tuam txhab tshuaj tshiab lossis biotech, peb tuaj yeem:

• Kev sib koom ua ke thaum ntxov: txheej txheem kev txhim kho + kev kuaj mob, cov nqi ntim khoom
• Tshaj tawm -hloov: pab hloov thev naus laus zis rau koj lub Hoobkas tsim, lossis ntev -lub sijhawm OEM
• Kev them nyiaj yug ua ntaub ntawv: kev koom tes nrog rau ntawm - kev tshuaj xyuas qhov chaw, muab cov ntaub ntawv

Txawm hais tias koj qhov project nyob rau theem twg hauv IND cov ntaub ntawv lossis kev sim tshuaj ntsuam xyuas, peb tuaj yeem muab cov kev pabcuam ua raws, txhim khu kev qha thiab muaj txiaj ntsig Clinical Peptides manufacturing services.

Kuv xav kom koj qhia kuv:
Peptide ib ntus lossis qauv (xws li NDA)
Tam sim no theem (IND, Phase I, Phase II, Phase III)
Yuav tsum muaj kev pab cuam dab tsi (kev pom zoo toxicology, kev pom zoo kho mob, kev pom zoo siv tau)
Batch loj (gram lossis kilograms)
Cov kev cai tshwj xeeb (ua tiav, ntim, cov ntaub ntawv)

Thaum twg koj xav tau nws?

Muab cov lus qhia ntxaws ntxaws thiab nqe lus rau koj hauv 24 teev.